[{"NetIncomeLoss_1_Q2_USD":-86142000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":3000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":35713000.0,"Depreciation_1_Q2_USD":17600000.0,"Depreciation_2_Q2_USD":33400000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-412227000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1489000.0,"InterestPaidNet_2_Q2_USD":3908000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":2551000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_Q2_USD":1564000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":139505000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":181909000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":94012000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":149727000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":148938000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":106685000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":220676000.0,"ConversionOfStockSharesIssued1_2_Q2_shares":2158991.0,"MarketableSecuritiesCurrent_0_Q2_USD":518731000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-650000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":516000.0,"ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_2_Q2_USD":-25000.0,"AssetsCurrent_0_Q2_USD":1504858000.0,"InterestExpenseOther_1_Q2_USD":260000.0,"InterestExpenseOther_2_Q2_USD":975000.0,"StockIssuedDuringPeriodValueAcquisitions_2_Q2_USD":28597000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":132751000.0,"ShareBasedCompensation_2_Q2_USD":69599000.0,"Assets_0_Q2_USD":4467735000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":764253000.0,"CommonStockSharesIssued_0_Q2_shares":149980798.0,"EquitySecuritiesFvNi_0_Q2_USD":1385000.0,"UnrecognizedTaxBenefits_0_Q2_USD":11300000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":1534383000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":40039000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":6638000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":27546000.0,"SellingAndMarketingExpense_1_Q2_USD":118862000.0,"SellingAndMarketingExpense_2_Q2_USD":286611000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_2_Q2_USD":25000.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":0.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":0.0,"OperatingLeaseExpense_2_Q2_USD":6860000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"DeferredIncomeTaxLiabilities_0_Q2_USD":26500000.0,"OperatingLeaseLiability_0_Q2_USD":136500000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":84666000.0,"StockIssuedDuringPeriodSharesAcquisitions_2_Q2_shares":382947.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":1501000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-867000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-2599000.0,"AccountsReceivableNetCurrent_0_Q2_USD":163608000.0,"ProceedsFromStockPlans_2_Q2_USD":9799000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":33632000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-7954000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":94217000.0,"RepaymentsOfConvertibleDebt_2_Q2_USD":150054000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":67433000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":3000.0,"DeferredCompensationArrangementWithIndividualSharesIssued_2_Q2_shares":136559.0,"ResearchAndDevelopmentExpense_1_Q2_USD":32673000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":76182000.0,"LongTermLoansPayable_0_Q2_USD":22944000.0,"OtherOperatingIncome_1_Q2_USD":23665000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":-333000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":1172548000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":678771000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":995604000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":10938000.0,"Liabilities_0_Q2_USD":1956542000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":3819798000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":126630000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":703926000.0,"OtherAssetsNoncurrent_0_Q2_USD":23902000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":23430000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":46769000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-47587000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-82936000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-190250000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q2_USD":3206000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2_Q2_USD":1564000.0,"IncreaseDecreaseInInventories_2_Q2_USD":20260000.0,"SharesIssuedPricePerShare_0_Q2_USD":86.94,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":1222939000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":268483000.0,"CostsAndExpenses_1_Q2_USD":359542000.0,"CostsAndExpenses_2_Q2_USD":789736000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":3000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-43419000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":83993000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":6654000.0,"AccountsPayableCurrent_0_Q2_USD":30998000.0,"LiabilitiesCurrent_0_Q2_USD":222274000.0,"CostOfRevenue_1_Q2_USD":77892000.0,"CostOfRevenue_2_Q2_USD":159498000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":679587000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-56697000.0,"InterestIncomeExpenseNet_1_Q2_USD":-22912000.0,"InterestIncomeExpenseNet_2_Q2_USD":-48065000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-87009000.0,"NonoperatingIncomeExpense_2_Q2_USD":-45056000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-194438000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1492000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":3206000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":110228000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":93724000.0,"PaymentForContingentConsiderationLiabilityInvestingActivities_2_Q2_USD":328000.0,"AmortizationOfFinancingCosts_1_Q2_USD":1139000.0,"AmortizationOfFinancingCosts_2_Q2_USD":1961000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":19000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":200000.0,"Goodwill_0_Q2_USD":1237672000.0,"NonoperatingIncomeExpense_1_Q2_USD":-20000000.0,"InterestExpense_2_Q2_USD":48065000.0,"InterestExpense_1_Q2_USD":22912000.0,"NetIncomeLoss_2_Q2_USD":-191839000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":463437000.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q2_USD":200000.0,"DebtSecuritiesAvailableForSaleRealizedGain_2_Q2_USD":100000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-626000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":12289000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":181909000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":904623000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":9799000.0,"EquitySecuritiesFvNiRealizedGainLoss_1_Q2_USD":400000.0,"EquitySecuritiesFvNiRealizedGainLoss_2_Q2_USD":300000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0683,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":1105115000.0,"InterestExpenseDebt_1_Q2_USD":22652000.0,"InterestExpenseDebt_2_Q2_USD":47090000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_1_Q2_USD":0.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":704208000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":36378000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":704208000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":640085000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":93345000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":8684000.0,"CommonStockSharesOutstanding_0_Q2_shares":149980798.0,"AmortizationOfDebtDiscountPremium_1_Q2_USD":18946000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":32677000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":40000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":69600000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":4467735000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-3222000.0,"PreferredStockValue_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":972056000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":30700000.0,"InvestmentIncomeInterest_1_Q2_USD":2912000.0,"InvestmentIncomeInterest_2_Q2_USD":3009000.0,"InventoryNet_0_Q2_USD":82215000.0,"ShortTermBankLoansAndNotesPayable_0_Q2_USD":1319000.0,"OperatingIncomeLoss_1_Q2_USD":-67009000.0,"OperatingIncomeLoss_2_Q2_USD":-149382000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":268868000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":616689000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OtherComprehensiveIncomeLossTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossTax_2_Q2_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":573665000.0,"OtherOperatingIncome_2_Q2_USD":23665000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_2_Q2_USD":1589000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":9871000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":1125547000.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"OciBeforeReclassificationsBeforeTaxAttributableToParent_2_Q2_USD":1564000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":30644000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":526680000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1_Q2_USD":1800000.0,"MarketableSecurities_0_Q2_USD":518731000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1311595000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":34638000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":268868000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":616689000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":762764000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":33455000.0,"StockholdersEquity_0_Q2_USD":2511193000.0,"OtherLiabilitiesCurrent_0_Q2_USD":40581000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":50311000.0,"ProfitLoss_2_Q2_USD":-191839000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.58,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.29,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":13024000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":47158000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"ConversionOfStockAmountConverted1_2_Q2_USD":0.0,"Ticker":"EXAS","CIK":"1124140","name":"EXACT SCIENCES CORP","OfficialName":"Exact Sciences Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"12010562930.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200731"}]